AKT-1768
A 83-year-old woman is terminally ill with metastatic breast cancer. Her General Practitioner (GP) reviews her at her home, with her family present. There is a discussion around treatment escalation, and a ‘just-in-case box’ is prescribed. The GP explains that in the last days of life, a syringe driver may be helpful to control symptoms such as pain, agitation, breathlessness or nausea.
Which of the following drugs is suitable for continuous subcutaneous infusion?